Managing COVID-19 in the oncology clinic and avoiding the distraction effect
- PMID: 32201224
- PMCID: PMC7174827
- DOI: 10.1016/j.annonc.2020.03.286
Managing COVID-19 in the oncology clinic and avoiding the distraction effect
Conflict of interest statement
Disclosure The authors have declared no conflicts of interest.
Figures
Comment in
-
SARS-CoV-2 disease and children under treatment for cancer.Pediatr Blood Cancer. 2020 Sep;67(9):e28346. doi: 10.1002/pbc.28346. Epub 2020 May 6. Pediatr Blood Cancer. 2020. PMID: 32374054 Free PMC article. No abstract available.
References
-
- Kamboj M., Sepkowitz K.A. Nosocomial infections in patients with cancer. Lancet Oncol. 2009;10:589–597. - PubMed
-
- Longbottom E.R., Torrance H.D., Owen H.C. Features of postoperative immune suppression are reversible with interferon gamma and independent of interleukin-6 pathways. Ann Surg. 2016;264:370–377. - PubMed
-
- Sica A., Massarotti M. Myeloid suppressor cells in cancer and autoimmunity. J Autoimmun. 2017;85:117–125. - PubMed
